ADMA Biologics logo
ADMA Biologics ADMA
€ 7.97 0.88%

Geschäftsbericht 2025
hinzugefügt 25.02.2026

report update icon

ADMA Biologics DSO 2011-2026 | ADMA

DSO Jährlich ADMA Biologics

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
74.6 33.1 30.3 52.2 94.3 114 43.2 29.9 62.2 34.9 47 - - - -

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert Mindestwert Durchschnitt
114 29.9 56

DSO Vierteljährlich ADMA Biologics

2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
84.1 78.2 59.4 - 30.6 33.9 42.9 - 46.1 48 33.7 - 44.2 59.9 85 - 96.9 99.5 81.3 - 118 155 74.7 - 43.8 48.3 62.9 31.3 30 27.3 59.5 - 74.9 104 85 - 31.6 40.9 41.7 - 45.5 64.4 39.7 - 25.6 23.4 11.2 - - 20 21 - 9.9 15.5 406 - - - -

Alle Zahlen in USD-Währung

Indikatorspanne aus vierteljährlicher Berichterstattung

Höchstwert Mindestwert Durchschnitt
406 9.9 62.7

DSO anderer Aktien in der Pharmaeinzelhändler

Name DSO Preis % 24h Marktkapitalisierung Land
Ascendis Pharma A/S Ascendis Pharma A/S
ASND
132 $ 229.25 0.44 % $ 5 B danmarkDanmark
I-Mab I-Mab
IMAB
271 - - $ 866 M chinaChina
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
84.7 - - $ 40.3 B usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
204 - -18.52 % $ 27.3 M britainBritain
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
2.75 K - -1.52 % $ 24.7 M usaUSA
AbbVie AbbVie
ABBV
258 $ 208.84 -2.86 % $ 369 B usaUSA
AbCellera Biologics AbCellera Biologics
ABCL
173 $ 3.52 0.28 % $ 1.05 B canadaCanada
Acorda Therapeutics Acorda Therapeutics
ACOR
48.3 - -24.86 % $ 820 K usaUSA
Adverum Biotechnologies Adverum Biotechnologies
ADVM
222 - - $ 86.2 M usaUSA
Advaxis Advaxis
ADXS
88.1 - -9.65 % $ 45.9 M usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
146 - 5.93 % $ 314 M canadaCanada
AgeX Therapeutics AgeX Therapeutics
AGE
186 - -10.17 % $ 12.2 K usaUSA
AIkido Pharma AIkido Pharma
AIKI
17.9 - 1.93 % $ 17.4 M usaUSA
Agenus Agenus
AGEN
3.58 $ 3.33 -2.06 % $ 99 M usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
216 - - $ 1.01 B usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
0.114 - - $ 26.5 M usaUSA
Alpine Immune Sciences Alpine Immune Sciences
ALPN
154 - - $ 2.17 B usaUSA
Adaptive Biotechnologies Corporation Adaptive Biotechnologies Corporation
ADPT
60.7 $ 14.81 2.63 % $ 2.25 B usaUSA
Altimmune Altimmune
ALT
7.85 K $ 3.34 7.05 % $ 294 M usaUSA
Amgen Amgen
AMGN
81.2 $ 347.94 -1.51 % $ 187 B usaUSA
ANI Pharmaceuticals ANI Pharmaceuticals
ANIP
114 $ 74.21 -2.3 % $ 1.43 B usaUSA
Aravive Aravive
ARAV
16.8 - -13.39 % $ 1.45 M usaUSA
Arcturus Therapeutics Holdings Arcturus Therapeutics Holdings
ARCT
21.2 $ 8.03 2.29 % $ 220 M israelIsrael
Aurinia Pharmaceuticals Aurinia Pharmaceuticals
AUPH
185 $ 15.61 0.9 % $ 2.1 B canadaCanada
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
58.2 $ 1.41 2.17 % $ 375 M britainBritain
Aptinyx Aptinyx
APTX
46.9 - -39.0 % $ 4.57 M usaUSA
Aytu BioScience Aytu BioScience
AYTU
150 $ 2.68 1.52 % $ 16.8 M usaUSA
CureVac N.V. CureVac N.V.
CVAC
13.6 - - $ 867 M germanyGermany
BioCryst Pharmaceuticals BioCryst Pharmaceuticals
BCRX
55.1 $ 9.02 -3.84 % $ 1.86 B usaUSA
Axon Enterprise Axon Enterprise
AXON
134 $ 412.81 -2.54 % $ 31.3 B usaUSA
Alnylam Pharmaceuticals Alnylam Pharmaceuticals
ALNY
58.1 $ 318.85 -3.01 % $ 41.8 B usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
61.7 - - $ 7.46 M israelIsrael